- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03011437
Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging
January 3, 2017 updated by: Bai Yang, Kashgar 1st People's Hospital
There are lack of endoscopic criteria for diagnosing Helicobacter pylori (H.
pylori) infection by conventional white light imaging (WLI).
Linked color imaging (LCI) is a newly developed endoscopy technique, which can diagnose mucosal lesions and H. pylori infection by enhancing color contrast of the mucosa.
The aim of the study is to investigate the ability of LCI for diagnosing H. pylori infection compared with WLI.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Helicobacter pylori (H.
pylori) is one of the most common chronic bacterial infections in man.
And it is the causative factor for peptic ulcer and regarded as a class I carcinogen for gastric adenocarcinoma.
Therefore, accurate detection of infection is crucial for devising proper eradication regimens and preventing the more severe GI complications.
Detection of H. pylori in the gastric mucosa can be performed via (1) direct detection of the bacterium; culture, histology and polymerase chain reaction or (2) indirect detection of its enzymatic products particularly urease and serum H. pylori-specific antibody examinations.
The direct detection methods are complicated and time-consuming.
While the indirect detection methods are less accurate.
With the wide use of endoscopy, diagnosis of H. pylori infection by endoscopy should be more accurate and easily available.
However, there are still lack of endoscopic criteria for diagnosing H. pylori infection by conventional white light imaging (WLI), which correlates poorly with histopathological findings of H. pylori-induced gastritis .
The newly modified LCI system (FUJIFILM Co.) can obtain clear and bright endoscopic images by using short-wavelength narrow-band laser light combined with white laser light.
LCI technique can enhance the color of the endoscopic images by digital processing, which makes red regions seem redder and white regions seem whiter.
Therefore, LCI may facilitate the detection of certain kinds of gastric lesions.
As the common thinking, H. pylori-associated gastritis regions are redder than normal mucosa under WLI because of hyperemia following inflammation.
And such redness can be enhanced by LCI.
However, there is no criterion for this estimating.
Red, green and blue (RGB) color model is a basic component system of the hue, of which each color is a composition of different proportions.
Thus, the color obtained by endoscopic images can be quantified by RGB model.
The study aimed at comparing the ability of WLI and LCI for diagnosing H. pylori infection by using RGB color model and investigating objective and quantifiable endoscopic criteria for predicting H. pylori infection.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Xinjiang
-
Kashgar, Xinjiang, China, 0998
- Recruiting
- First People's Hospital of Kashgar Region
-
Contact:
- Bai Yang, Doctor
- Phone Number: 15626498226
- Email: baiyang1665@163.com
-
Principal Investigator:
- Bai Yang, Doctor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
People who undergo esophagogastroduodenoscopy in the First People's Hospital of Kashgar Region.
All patients provided written informed consents to undergo esophagogastroduodenoscopy and participate in this study.
Description
Inclusion Criteria:
- People who undergo esophagogastroduodenoscopy for possible upper gastrointestinal disease
Exclusion Criteria:
- Patients who have taken proton pump inhibitor, antibiotics, non-steroidal anti-inflammatory drugs, bismuth agent, H2-receptor inhibitor and medicines that can affect the test of H. pylori infection in a month
- Patients with severe systematic disorders
- Patients with accurate gastrointestinal bleeding in a week
- Patients with histories of gastric surgery
- Pregnant and lactating women
- Patients with poor coagulation function
- Patients diagnosed with gastric cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
cases
Patients who undergo esophagogastroduodenoscopy during 01/12/2016 and 31/12/2016 in the First People's Hospital of Kashgar Region.
|
Esophagogastroduodenoscopy is an examining method for upper gastrointestinal disease.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Accuracy, specificity and sensitivity of LCI for diagnosing Hp infection compared with the pathology
Time Frame: one month
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hp infection rate
Time Frame: one month
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Zou X Guang, First People's Hospital of Kashgar Region
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2016
Primary Completion (ANTICIPATED)
January 1, 2017
Study Completion (ANTICIPATED)
January 1, 2017
Study Registration Dates
First Submitted
December 28, 2016
First Submitted That Met QC Criteria
January 3, 2017
First Posted (ESTIMATE)
January 5, 2017
Study Record Updates
Last Update Posted (ESTIMATE)
January 5, 2017
Last Update Submitted That Met QC Criteria
January 3, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016A020212007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori Infection
-
Second Affiliated Hospital, School of Medicine,...CompletedHelicobacter Pylori Infection | Helicobacter Pylori Eradication AntibioticChina
-
Tanta UniversityRecruitingHELICOBACTER PYLORI INFECTIONS | Helicobacter Infection | Helicobacter Pylori Gastrointestinal Tract Infection | Helicobacter Pylori Infected PatientsEgypt
-
Christopher C. Thompson, MD, MScErbe Elektromedizin GmbHRecruitingHelicobacter Pylori Infection | H. Pylori Infection | Helicobacter Pylori | Helicobacter Pylori Gastrointestinal Tract Infection | H. Pylori Gastrointestinal DiseaseUnited States
-
Daewoong Pharmaceutical Co. LTD.iNtherapeutics Co. LTDCompletedHelicobacter Pylori Infection | Helicobacter Pylori Infected Subjects | Helicobacter Pylori Infected PatientsSouth Korea
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Peking University First HospitalRecruitingHelicobacter Pylori InfectionChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Kaohsiung Medical UniversityKaohsiung Veterans General Hospital.RecruitingHelicobacter Pylori InfectionTaiwan
-
Yueyue LiQilu Hospital of Shandong University; Shandong University of Traditional Chinese... and other collaboratorsRecruitingHelicobacter Pylori InfectionChina
-
Yueyue LiQilu Hospital of Shandong University; Shandong University of Traditional Chinese... and other collaboratorsCompletedHelicobacter Pylori InfectionChina
Clinical Trials on Esophagogastroduodenoscopy
-
Sohag UniversityRecruitingChronic Kidney DiseasesEgypt
-
Chinese University of Hong KongRecruitingIntestinal Metaplasia | Helicobacter Pylori | Atrophic GastritisHong Kong
-
Copenhagen University Hospital, HvidovreCompletedDuodenal Cancer | Duodenal Polyposis | Familial Adenomatous PolyposesDenmark
-
Rutgers, The State University of New JerseyRecruitingGastric CancerUnited States
-
Nanfang Hospital of Southern Medical UniversityLanZhou University; Zhongda Hospital; Ankara University; Xingtai People's Hospital and other collaboratorsRecruitingCompensated CirrhosisChina, Turkey, Thailand
-
Instituto Ecuatoriano de Enfermedades DigestivasUnknownPortal Hypertension | Liver CirrhosesEcuador
-
University of California, Los AngelesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEsophageal VaricesUnited States
-
Queen's UniversityCompletedAnemia | Colon PolypsCanada
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedIntestinal Metaplasia | Gastritis Chronic | Gastritis H PyloriTurkey
-
The Cleveland ClinicCompletedColonoscopy | EsophagogastroduodenoscopyUnited States